Key result
Statins provide cardiovascular protection through pleiotropic mechanisms like reducing inflammation and improving endothelial function.
Answers are grounded in this paper and cite their sources.
Review shows that statin pleiotropic effects reduce cardiovascular risk beyond lipid lowering, indicating early vascular protection through plaque stabilization and anti-inflammatory pathways.
PURPOSE OF REVIEW: 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) are the most widely prescribed drugs worldwide for lowering cholesterol levels. In use for more than 15 years, they have demonstrated efficacy, safety, and tolerability across a broad range of patients. This class of drugs has been designed to lower the cholesterol level by competitively inhibiting the enzyme responsible for its biosynthesis and thereby to play a major role in reducing cardiovascular risk. However, both basic evidence and clinical evidence also supports the idea that reductions in cardiovascular risk are dependent on mechanisms beyond cholesterol reduction alone, such as the reduction of endothelial dysfunction, inhibition of inflammatory responses, stabilization of atherosclerotic plaques, and modulation of procoagulant activity and platelet function. RECENT FINDINGS: In fact, as shown in several clinical trials, the beneficial effects of statin treatment begin earlier than its cholesterol-lowering effect. These other mechanisms could act in concert with the potent low-density lipoprotein cholesterol-lowering effects of this class of drugs to exert early and lasting cardiovascular protective effects. Recently, several studies have shown that an intensive lipid-lowering regimen with a statin provides greater protection against death or major cardiovascular events than does a standard regimen. SUMMARY: This review summarizes the new findings in these pleiotropic effects and describes their impact on vascular processes.
No takes yet. Share an insight, caveat, or question.
Calabr et al. (2005) conducted a review in Cardiovascular risk. Statins was evaluated. Statins exert cardiovascular protective effects through pleiotropic mechanisms beyond cholesterol reduction alone, such as improving endothelial dysfunction and inhibiting inflammation.
Synapse has enriched 10 related papers. Consider them for comparative context: